MRKR Price / Book | MARKER THERAPEUTICS, INC.

Marker Therapeutics, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Marker Therapeutics, Inc. price/book ratio for the quarter ending 2026-06-30 was 2.05, a 23.30% increase year-over-year.
Marker Therapeutics, Inc. price/book ratio for the quarter ending 2026-03-31 was 1.57, a 65.54% increase year-over-year.
Marker Therapeutics, Inc. price/book ratio for the quarter ending 2025-12-31 was 1.45, a 19.05% decline year-over-year.
Marker Therapeutics, Inc. price/book ratio for the quarter ending 2025-09-30 was 0.8, a 76.11% decline year-over-year.
Marker Therapeutics, Inc. price/book ratio for fiscal 2026 was 2.05.
Marker Therapeutics, Inc. price/book ratio for fiscal 2025 was 1.45, a 19.05% decline from fiscal 2024.
Marker Therapeutics, Inc. price/book ratio for fiscal 2024 was 1.79, a 48.52% decline from fiscal 2023.
Marker Therapeutics, Inc. price/book ratio for fiscal 2023 was 3.48, a 201.05% increase from fiscal 2022.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.05	$24.88M	$12.17M
2026-03-31	1.57	$21.71M	$13.8M
2025-12-31	1.45	$24.38M	$16.8M
2025-09-30	0.8	$14.8M	$18.39M
2025-06-30	1.66	$17.4M	$10.49M
2025-03-31	0.95	$13.78M	$14.49M
2024-12-31	1.79	$33.28M	$18.56M
2024-09-30	3.37	$25.1M	$7.45M
2024-06-30	4.98	$48.33M	$9.7M
2024-03-31	3.25	$38.27M	$11.79M
2023-12-31	3.48	$48.95M	$14.05M
2023-09-30	2.39	$39.95M	$16.71M
2023-06-30	1.43	$27.28M	$19.03M
2023-03-31	0.39	$6.25M	$15.91M
2022-12-31	1.16	$22.68M	$19.6M
2022-09-30	13.69	$309.32M	$22.6M
2022-06-30	9.84	$275.88M	$28.03M
2022-03-31	10.29	$367.4M	$35.71M
2021-12-31	1.79	$78.85M	$43.99M
2021-09-30	26.86	$1.4B	$52.28M
2021-06-30	36.66	$2.32B	$63.24M
2021-03-31	25.65	$1.86B	$72.49M
2020-12-31	26.88	$735.15M	$27.34M
2020-09-30	23.53	$720M	$30.6M
2020-06-30	27.95	$964.62M	$34.51M
2020-03-31	22.37	$883.5M	$39.5M
2019-12-31	29.85	$1.32B	$44.09M
2019-09-30	48.77	$2.34B	$47.88M
2019-06-30	70.1	$3.6B	$51.4M
2019-03-31	54	$3B	$55.61M
2018-12-31	42.46	$2.52B	$59.34M
2018-09-30	1,808.78	$1.25B	$690,467.00
2018-06-30	309.44	$1.28B	$4.14M
2018-03-31	581.66	$358.28M	$615,959.00
2017-12-31	113.59	$415.52M	$3.66M
2017-09-30	53.24	$316.05M	$5.94M
2017-06-30	46.02	$394.17M	$8.57M
2017-03-31	91.85	$380.34M	$4.14M
2016-12-31	52.7	$325.92M	$6.18M
2016-09-30	74.95	$561.68M	$7.49M
2016-06-30	-226.11	$4.37B	-$19.33M
2016-03-31	-225.36	$5.79B	-$25.7M
2015-12-31	-19.83	$423.57M	-$21.36M
2015-09-30	-170.83	$4.68B	-$27.39M
2015-06-30	-64.35	$4.38B	-$68.1M
2015-03-31	-94.46	$822.5M	-$8.71M
2014-12-31	-666.95	$682.71M	-$1.02M
2014-09-30	-2,258.55	$1.48B	-$656,195.00
2014-06-30	-1,518.92	$3.89B	-$2.56M
2014-03-31	-1,295.19	$7.13B	-$5.51M
2013-12-31	-40.12	$351.77M	-$8.77M
2013-09-30	-3,393.71	$17.32B	-$5.1M
2013-03-31	-19,219.15	$91.68B	-$4.77M
2012-12-31	-182.08	$1.1B	-$6.04M
2012-09-30	-24,352.59	$106.36B	-$4.37M
2012-06-30	-21,164	$78.24B	-$3.7M
2012-03-31	-27,123.55	$97.79B	-$3.61M
2011-12-31	-27,087.42	$93.73B	-$3.46M
2011-09-30	-39,175.82	$85.25B	-$2.18M
2011-06-30	-78,764.38	$140.43B	-$1.78M
2010-12-31	-21,237.37	$82.12B	-$3.87M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.05	$24.88M	$12.17M
2025-12-31	1.45	$24.38M	$16.8M
2024-12-31	1.79	$33.28M	$18.56M
2023-12-31	3.48	$48.95M	$14.05M
2022-12-31	1.16	$22.68M	$19.6M
2021-12-31	1.79	$78.85M	$43.99M
2020-12-31	26.88	$735.15M	$27.34M
2019-12-31	29.85	$1.32B	$44.09M
2018-12-31	42.46	$2.52B	$59.34M
2017-12-31	113.59	$415.52M	$3.66M
2016-12-31	52.7	$325.92M	$6.18M
2015-12-31	-19.83	$423.57M	-$21.36M
2014-12-31	-666.95	$682.71M	-$1.02M
2013-12-31	-40.12	$351.77M	-$8.77M
2012-12-31	-182.08	$1.1B	-$6.04M
2011-12-31	-27,087.42	$93.73B	-$3.46M
2010-12-31	-21,237.37	$82.12B	-$3.87M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Neuphoria Therapeutics Inc. (NEUP)	United States	$0.020B	-1.77
Cellectar Biosciences, Inc. (CLRB)	United States	$0.020B	-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)	United States	$0.019B	-0.31
Rocket One Inc. (RKTO)	United States	$0.019B
ATOSSA THERAPEUTICS, INC. (ATOS)	United States	$0.021B	-0.52
Biofrontera Inc. (BFRI)	United States	$0.018B	-2.13
Cocrystal Pharma, Inc. (COCP)	United States	$0.022B
Lipocine Inc. (LPCN)	United States	$0.017B	-1.79
PALATIN TECHNOLOGIES INC (PTN)	United States	$0.017B	-5.36
Allarity Therapeutics, Inc. (ALLR)	United States	$0.017B	-1.66